Private Equity PE Fund Investments
Specialty pharma co. OneSource attracts $95-M led by HBM Healthcare Investments
Source Business Line (opens in a new tab)Press Release (opens in a new tab)
Bengaluru-headquartered OneSource Specialty Pharma Ltd (formerly known as Stelis Biopharma Ltd), a subsidiary of publicly listed Strides Pharma Science Ltd, has received equity commitments worth INR 801 crore (USD 95 million) from PE investors at a pre-money valuation of USD 1.65 Billion. The funding round was led by HBM Healthcare Investments with participation from WhiteOak Capital, Param Capital, Motilal Oswal, Enam Holdings and SBI Life Insurance.DSK Legal acted as the legal counsel for OneSource and Transaction Square was the financial advisor.OneSource is a CDMO (Contract Development and Manufacturing Organization). The funds will be used to accelerate growth, manage debt and support capital expenditure for the company’s order book.